Display options
Share it on

Oncoscience. 2015 Apr 28;2(4):320-33. doi: 10.18632/oncoscience.155. eCollection 2015.

AID/APOBEC deaminases and cancer.

Oncoscience

Stefan Rebhandl, Michael Huemer, Richard Greil, Roland Geisberger

Affiliations

  1. Department of internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria ; Salzburg Cancer Research Institute, Salzburg, Austria.

PMID: 26097867 PMCID: PMC4468319 DOI: 10.18632/oncoscience.155

Abstract

Mutations are the basis for evolution and the development of genetic diseases. Especially in cancer, somatic mutations in oncogenes and tumor suppressor genes alongside the occurrence of passenger mutations have been observed by recent deep-sequencing approaches. While mutations have long been considered random events induced by DNA-replication errors or by DNA damaging agents, genome sequencing led to the discovery of non-random mutation signatures in many human cancer. Common non-random mutations comprise DNA strand-biased mutation showers and mutations restricted to certain DNA motifs, which recently have become attributed to the activity of the AID/APOBEC family of DNA deaminases. Hence, APOBEC enzymes, which have evolved as key players in natural and adaptive immunity, have been proposed to contribute to cancer development and clonal evolution of cancer by inducing collateral genomic damage due to their DNA deaminating activity. This review focuses on how mutagenic events through AID/APOBEC deaminases may contribute to cancer development.

Keywords: AID; APOBEC3; cancer; deamination; kataegis; mutation cluster; mutation signature

References

  1. Annu Rev Genet. 2004;38:445-76 - PubMed
  2. Genomics. 2002 Mar;79(3):285-96 - PubMed
  3. Biomed Rep. 2014 May;2(3):392-395 - PubMed
  4. Int J Cancer. 2008 Dec 15;123(12):2735-40 - PubMed
  5. Cell. 2014 Dec 18;159(7):1524-37 - PubMed
  6. Nature. 2008 Feb 14;451(7180):841-5 - PubMed
  7. Genome Biol. 2008;9(6):229 - PubMed
  8. Gastroenterology. 2010 Dec;139(6):1984-94 - PubMed
  9. Curr Biol. 2002 Oct 15;12(20):1748-55 - PubMed
  10. Nature. 2013 Feb 21;494(7437):366-70 - PubMed
  11. Science. 1993 Jun 18;260(5115):1816-9 - PubMed
  12. Nucleic Acids Res. 2010 Jul;38(13):4274-84 - PubMed
  13. Cell. 2000 Sep 1;102(5):565-75 - PubMed
  14. Oncotarget. 2015 Feb 20;6(5):3409-19 - PubMed
  15. Nature. 2003 Apr 17;422(6933):726-30 - PubMed
  16. Cell Cycle. 2005 Sep;4(9):1281-5 - PubMed
  17. Cell. 2014 Dec 18;159(7):1538-48 - PubMed
  18. Annu Rev Biochem. 2007;76:1-22 - PubMed
  19. Cell Cycle. 2013 Mar 1;12(5):762-72 - PubMed
  20. BMC Mol Biol. 2008 Nov 18;9:104 - PubMed
  21. Cell Rep. 2014 Jun 12;7(5):1640-8 - PubMed
  22. J Exp Med. 2009 Jan 16;206(1):99-111 - PubMed
  23. J Exp Med. 2011 Nov 21;208(12):2385-91 - PubMed
  24. Mol Cell. 2012 May 25;46(4):424-35 - PubMed
  25. J Biol Chem. 2013 Oct 11;288(41):29294-304 - PubMed
  26. Oncogene. 2007 Aug 16;26(38):5587-95 - PubMed
  27. Sci Rep. 2012;2:806 - PubMed
  28. J Virol. 2011 Aug;85(16):8197-207 - PubMed
  29. Int Immunol. 2004 Mar;16(3):395-404 - PubMed
  30. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2634-8 - PubMed
  31. Blood. 2009 Feb 19;113(8):1862-4; author reply 1864 - PubMed
  32. Biol Direct. 2012 Dec 18;7:47; discussion 47 - PubMed
  33. Eur J Immunol. 2014 Dec;44(12):3747-57 - PubMed
  34. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4102-7 - PubMed
  35. PLoS One. 2014 May 23;9(5):e97787 - PubMed
  36. Mol Cell. 2008 Aug 22;31(4):474-84 - PubMed
  37. J Immunol. 2010 Mar 1;184(5):2487-91 - PubMed
  38. Nat Struct Mol Biol. 2010 Sep;17(9):1124-35 - PubMed
  39. J Biol Chem. 1999 Jun 25;274(26):18470-6 - PubMed
  40. J Virol. 2004 Jun;78(11):6073-6 - PubMed
  41. PLoS One. 2012;7(2):e30667 - PubMed
  42. J Mol Biol. 2004 Mar 26;337(3):585-96 - PubMed
  43. Eur J Immunol. 2014 Jul;44(7):2175-87 - PubMed
  44. Leukemia. 2014 Sep;28(9):1929-32 - PubMed
  45. BMC Med Genomics. 2014 Feb 19;7:11 - PubMed
  46. J Exp Med. 2008 Jun 9;205(6):1357-68 - PubMed
  47. Nature. 2014 Oct 16;514(7522):389-93 - PubMed
  48. PLoS Genet. 2008 Nov;4(11):e1000264 - PubMed
  49. Semin Cell Dev Biol. 2012 May;23(3):258-68 - PubMed
  50. J Immunol. 2010 Aug 1;185(3):1379-81 - PubMed
  51. Genomics. 1994 Nov 15;24(2):414-5 - PubMed
  52. Biomed Res Int. 2013;2013:683095 - PubMed
  53. Nat Rev Immunol. 2012 Jun 25;12(7):517-31 - PubMed
  54. Int J Cancer. 2015 Sep 15;137(6):1249-57 - PubMed
  55. Cancer Immunol Immunother. 2012 Sep;61(9):1591-8 - PubMed
  56. Biochim Biophys Acta. 2000 Nov 15;1494(1-2):1-13 - PubMed
  57. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8403-8 - PubMed
  58. Blood. 1998 Jun 1;91(11):4292-9 - PubMed
  59. Nucleic Acids Res. 2007;35(9):2955-64 - PubMed
  60. Nat Immunol. 2011 Feb;12(2):160-6 - PubMed
  61. J Exp Med. 2003 May 5;197(9):1173-81 - PubMed
  62. Nat Struct Mol Biol. 2010 Feb;17(2):222-9 - PubMed
  63. Nature. 2010 Feb 25;463(7284):1101-5 - PubMed
  64. Proc Natl Acad Sci U S A. 2014 May 27;111(21):7759-64 - PubMed
  65. Science. 1998 Jun 12;280(5370):1750-2 - PubMed
  66. PLoS One. 2008;3(12):e3927 - PubMed
  67. Elife. 2014 Apr 29;3:e02001 - PubMed
  68. J Exp Med. 2000 Dec 18;192(12):1833-40 - PubMed
  69. Cell. 2010 Oct 1;143(1):122-33 - PubMed
  70. Curr Top Microbiol Immunol. 2013;371:1-27 - PubMed
  71. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6 - PubMed
  72. Cell Rep. 2014 Jun 26;7(6):1833-41 - PubMed
  73. Immune Netw. 2012 Dec;12(6):230-9 - PubMed
  74. Int J Oncol. 2008 Aug;33(2):261-70 - PubMed
  75. Biochemistry (Mosc). 2011 Jan;76(1):131-46 - PubMed
  76. Mol Biol Evol. 2005 Feb;22(2):367-77 - PubMed
  77. Biochim Biophys Acta. 1992 Nov 15;1171(1):11-8 - PubMed
  78. Curr Biol. 2002 Mar 5;12(5):435-8 - PubMed
  79. Genomics. 2000 Aug 15;68(1):85-8 - PubMed
  80. Nat Immunol. 2013 Jul;14(7):749-55 - PubMed
  81. Nature. 2010 Feb 25;463(7284):1042-7 - PubMed
  82. Nature. 2002 Jul 4;418(6893):99-103 - PubMed
  83. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1982-6 - PubMed
  84. J Exp Med. 2003 Nov 3;198(9):1427-37 - PubMed
  85. Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6736-41 - PubMed
  86. Mol Cell Biol. 2005 Aug;25(16):7270-7 - PubMed
  87. Elife. 2013 Apr 16;2:e00534 - PubMed
  88. Curr Biol. 2004 Aug 10;14 (15):1392-6 - PubMed
  89. J Biol Chem. 1993 Oct 5;268(28):20709-12 - PubMed
  90. Nat Struct Mol Biol. 2011 Feb;18(2):230-6 - PubMed
  91. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1975-80 - PubMed
  92. Nature. 2004 Aug 26;430(7003):992-8 - PubMed
  93. Ann Surg Oncol. 2011 Jul;18(7):2084-92 - PubMed
  94. Cell. 2008 Dec 26;135(7):1201-12 - PubMed
  95. Nature. 2005 Nov 24;438(7067):508-11 - PubMed
  96. J Biol Chem. 2010 Jul 30;285(31):23945-53 - PubMed
  97. J Biol Chem. 2010 Mar 5;285(10 ):7111-8 - PubMed
  98. Science. 2014 Oct 10;346(6206):251-6 - PubMed
  99. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2977-86 - PubMed
  100. Nature. 2013 Aug 22;500(7463):415-21 - PubMed
  101. Cell. 2012 May 25;149(5):979-93 - PubMed
  102. Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8798-803 - PubMed
  103. Nat Rev Cancer. 2005 Apr;5(4):251-62 - PubMed
  104. Gastroenterology. 2014 Aug;147(2):407-17.e3 - PubMed
  105. Leukemia. 2004 Apr;18(4):826-31 - PubMed
  106. J Mol Biol. 2012 Jun 22;419(5):301-14 - PubMed
  107. J Exp Med. 2008 Oct 27;205(11):2585-94 - PubMed
  108. Trends Biochem Sci. 2003 Jun;28(6):305-12 - PubMed
  109. Nat Rev Immunol. 2004 Jul;4(7):541-52 - PubMed
  110. Nat Genet. 2008 Jan;40(1):108-12 - PubMed
  111. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2385-8 - PubMed
  112. Cell. 2011 Sep 30;147(1):95-106 - PubMed
  113. Cell. 2004 Aug 20;118(4):431-8 - PubMed
  114. Nature. 1993 Apr 22;362(6422):709-15 - PubMed
  115. Blood. 2008 Dec 1;112(12):4675-82 - PubMed
  116. BMC Evol Biol. 2012 May 28;12:71 - PubMed
  117. Reproduction. 2011 Nov;142(5):621-32 - PubMed
  118. Cell. 2000 Sep 1;102(5):553-63 - PubMed
  119. Nat Genet. 2014 May;46(5):487-91 - PubMed
  120. J Exp Med. 2010 Nov 22;207 (12 ):2751-65 - PubMed
  121. J Clin Invest. 2011 Nov;121(11):4526-36 - PubMed
  122. Ann N Y Acad Sci. 2012 Sep;1267:79-85 - PubMed
  123. J Immunol. 2011 Sep 1;187(5):2464-75 - PubMed
  124. EMBO J. 2004 Jun 16;23(12):2451-8 - PubMed
  125. Blood. 2012 Jul 12;120(2):366-75 - PubMed
  126. Mol Immunol. 2006 Mar;43(8):1099-108 - PubMed
  127. Biochem Biophys Res Commun. 1999 Jul 5;260(2):398-404 - PubMed
  128. EMBO J. 2012 Feb 1;31(3):679-91 - PubMed
  129. Cancer Res. 2013 Dec 15;73(24):7222-31 - PubMed
  130. Mol Cell Biol. 2011 Feb;31(3):442-9 - PubMed
  131. Nat Genet. 2013 Sep;45(9):970-6 - PubMed
  132. Nature. 2002 Aug 8;418(6898):646-50 - PubMed
  133. Mol Cell Biol. 2000 Mar;20(6):1982-92 - PubMed
  134. Annu Rev Immunol. 2008;26:317-53 - PubMed
  135. Nat Med. 2007 Apr;13(4):470-6 - PubMed
  136. Nature. 2003 Jul 3;424(6944):103-7 - PubMed
  137. Nat Immunol. 2003 Jun;4(6):586-93 - PubMed
  138. Mol Cell. 2002 Nov;10 (5):1247-53 - PubMed
  139. Leukemia. 2008 Oct;22(10 ):1917-24 - PubMed
  140. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11816-21 - PubMed
  141. Cancer Res. 2013 Jun 15;73(12 ):3494-8 - PubMed
  142. Nature. 2013 Oct 17;502(7471):389-92 - PubMed
  143. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4126-31 - PubMed
  144. Elife. 2014 May 20;3:e03068 - PubMed
  145. J Natl Cancer Inst. 2013 Apr 17;105(8):573-9 - PubMed
  146. Nat Rev Immunol. 2004 Nov;4(11):868-77 - PubMed
  147. Curr Biol. 2004 Aug 10;14 (15):1385-91 - PubMed

Publication Types

Grant support